Literature DB >> 15199347

Caffeinated coffee consumption and mortality after acute myocardial infarction.

Kenneth J Mukamal1, Malcolm Maclure, James E Muller, Jane B Sherwood, Murray A Mittleman.   

Abstract

BACKGROUND: Previous studies have generally suggested no effect of coffee consumption on the risk of acute myocardial infarction. The effect of coffee consumption on prognosis after acute myocardial infarction is uncertain.
METHODS: In an inception cohort study, we observed 1935 patients who were hospitalized with a confirmed acute myocardial infarction between 1989 and 1994 at 45 community hospitals and tertiary care centers in the United States, as part of the Determinants of Myocardial Infarction Onset Study. Trained interviewers assessed self-reported caffeinated coffee consumption before infarction with a standardized questionnaire. We analyzed survival censored at December 31, 1995, using Cox proportional hazards regression.
RESULTS: Of the 1902 patients for whom we had information on coffee intake, 315 (17%) died during a median follow-up period of 3.8 years. Coffee drinkers tended to be men, younger, and free of comorbidity, and they were more likely to be current smokers. Coffee consumption was not associated with an overall change in long-term post-infarction mortality rate. However, we did observe an unexpected and unexplained variation in the association between coffee consumption and mortality with time, with an apparent inverse association in the first 90 days after infarction.
CONCLUSIONS: Self-reported coffee consumption has no overall association with post-infarction mortality. The unexpected time variation in the effect of coffee intake requires evaluation in other studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15199347     DOI: 10.1016/j.ahj.2003.12.038

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

1.  An exploratory prospective study of marijuana use and mortality following acute myocardial infarction.

Authors:  Kenneth J Mukamal; Malcolm Maclure; James E Muller; Murray A Mittleman
Journal:  Am Heart J       Date:  2008-03       Impact factor: 4.749

Review 2.  Coffee consumption and cardiovascular health: getting to the heart of the matter.

Authors:  Salome A Rebello; Rob M van Dam
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

3.  Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study.

Authors:  Annlia Paganini-Hill; Claudia H Kawas; María M Corrada
Journal:  Prev Med       Date:  2006-12-29       Impact factor: 4.018

Review 4.  [Coffee and cardiovascular diseases].

Authors:  Mariano de la Figuera von Wichmann
Journal:  Aten Primaria       Date:  2009-09-23       Impact factor: 1.137

5.  Coffee consumption and mortality in women with cardiovascular disease.

Authors:  Esther Lopez-Garcia; Fernando Rodriguez-Artalejo; Tricia Y Li; Kenneth J Mukamal; Frank B Hu; Rob M van Dam
Journal:  Am J Clin Nutr       Date:  2011-05-11       Impact factor: 7.045

6.  Coffee consumption after myocardial infarction and risk of cardiovascular mortality: a prospective analysis in the Alpha Omega Cohort.

Authors:  Laura H van Dongen; Famke Jm Mölenberg; Sabita S Soedamah-Muthu; Daan Kromhout; Johanna M Geleijnse
Journal:  Am J Clin Nutr       Date:  2017-08-23       Impact factor: 7.045

7.  Soda consumption and the risk of stroke in men and women.

Authors:  Adam M Bernstein; Lawrence de Koning; Alan J Flint; Kathryn M Rexrode; Walter C Willett
Journal:  Am J Clin Nutr       Date:  2012-04-04       Impact factor: 7.045

8.  Green Tea and Coffee Consumption and All-Cause Mortality Among Persons With and Without Stroke or Myocardial Infarction.

Authors:  Masayuki Teramoto; Isao Muraki; Kazumasa Yamagishi; Akiko Tamakoshi; Hiroyasu Iso
Journal:  Stroke       Date:  2021-02-04       Impact factor: 7.914

Review 9.  Habitual coffee consumption and blood pressure: an epidemiological perspective.

Authors:  Johanna M Geleijnse
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.

Authors:  Remo H M Furtado; Ramkumar V Venkateswaran; Jose C Nicolau; Yared Gurmu; Deepak L Bhatt; Robert F Storey; P Gabriel Steg; Giuglia Magnani; Shinya Goto; Mikael Dellborg; Gabriel Kamensky; Daniel Isaza; Philip Aylward; Per Johanson; Marc P Bonaca
Journal:  J Am Heart Assoc       Date:  2020-05-15       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.